» Articles » PMID: 39166681

Comparison of Obstetric and Perinatal Complications in Intracytoplasmic Sperm Injection Cycles with Autologous Oocytes and Donated Oocytes

Abstract

Objective: The aim of this study was to compare the obstetric and perinatal complications in women who became pregnant with autologous oocytes and those who received donated oocytes (DO) in intracytoplasmic sperm injection cycles (ICSI).

Methods: A retrospective cohort study was carried out by collecting data from medical records between 2019 and 2022. Only patients who underwent ICSI in an induced cycle using their own or freshly DO, with male infertility factor and tubal factor, were included.

Results: A total of 120 patients were assessed, comprising 51 cases utilizing their own oocytes (control group) and 69 cases employing DO (study group). Patients receiving DO (n=69) exhibited a significantly higher mean age compared to those utilizing their own oocytes (n=51) (41.96±2.16 vs 38.54±1.42 years, p<0.001). There was no significant association between the source of oocytes and gestational age at delivery (p=0.296), birth weight (p=0.836), admission to neonatal intensive care unit (ICU) (p=0.120), or maternal admission to adult ICU (p=0.767). Additionally, the origin of oocytes did not demonstrate any significant association with the risk of pre-eclampsia (p=0.357), gestational diabetes mellitus (p=0.187), premature rupture of membranes (p=0.996), uterine atony (p=0.996), placenta previa (p=0.393), oligohydramnios (p=0.393), or gestational hypertension (p=0.393)."

Conclusion: An increase in obstetric and perinatal complications was not observed in pregnancies with DO compared to pregnancies with autologous oocytes in women undergoing ICSI without prior comorbidities. Further studies with larger sample sizes are required to validate our findings.

References
1.
Boerma T, Ronsmans C, Melesse D, Barros A, Barros F, Juan L . Global epidemiology of use of and disparities in caesarean sections. Lancet. 2018; 392(10155):1341-1348. DOI: 10.1016/S0140-6736(18)31928-7. View

2.
Tian X, Eikmans M, van der Hoorn M . The Role of Macrophages in Oocyte Donation Pregnancy: A Systematic Review. Int J Mol Sci. 2020; 21(3). PMC: 7037275. DOI: 10.3390/ijms21030939. View

3.
Yadav V, Bakolia P, Malhotra N, Mahey R, Singh N, Kriplani A . Comparison of Obstetric Outcomes of Pregnancies after Donor-Oocyte Fertilization and Self-Oocyte Fertilization: A Retrospective Cohort Study. J Hum Reprod Sci. 2019; 11(4):370-375. PMC: 6333036. DOI: 10.4103/jhrs.JHRS_115_17. View

4.
Vander Borght M, Wyns C . Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018; 62:2-10. DOI: 10.1016/j.clinbiochem.2018.03.012. View

5.
van Bentem K, Lashley E, Bos M, Eikmans M, Heidt S, Claas F . Relating the number of human leucocytes antigen mismatches to pregnancy complications in oocyte donation pregnancies: study protocol for a prospective multicentre cohort study (DONOR study). BMJ Open. 2019; 9(7):e027469. PMC: 6661658. DOI: 10.1136/bmjopen-2018-027469. View